Cardiometabolic multimorbidity is common among patients with psoriasis and is associated with poorer outcomes compared to those without comorbidity

Cardiometabolic multimorbidity is common among patients with psoriasis and is associated with poorer outcomes compared to those without comorbidity

Background Associations between cardiometabolic multimorbidity and response to therapy in psoriasis are unknown. Objective Determine the associations of multimorbidity with response to biologic treatment in psoriasis patients. Methods CorEvitas Psoriasis Registry participants who initiated biologic...

Full description

Bibliographic Details
Main Authors: Clinton W. Enos, Vanessa L. Ramos, Robert R. McLean, Tin-Chi Lin, Nicole Foster, Blessing Dube, Abby S. Van Voorhees
Format: Article
Language:English
Published: Taylor & Francis Group 2022-10-01
Series:Journal of Dermatological Treatment
Subjects:
psoriasis
multimorbidity
comorbid disease
metabolic disease
biologics
biologic therapy
psoriatic disease
outcomes
treatment response
Online Access:http://dx.doi.org/10.1080/09546634.2022.2089329

Internet

http://dx.doi.org/10.1080/09546634.2022.2089329

Similar Items